Divi's Laboratories Limited, Unit-2 has been inspected by US-FDA from September 11 to September 19, 2017.
This inspection was for full cGMP and verification of all Corrective Actions proposed against the previous Inspection observations. Divi's Laboratories Limited announces that all previous observations have been confirmed as completed and resolved.
On completion of this inspection, Divi's Laboratories Limited has received a Form 483 citing six observations which are procedural and the company will be responding to these within the stipulated time.
Shares of DIVI'S LABORATORIES LTD. was last trading in BSE at Rs.942.75 as compared to the previous close of Rs. 863.85. The total number of shares traded during the day was 1860805 in over 39054 trades.
The stock hit an intraday high of Rs. 950 and intraday low of 866.45. The net turnover during the day was Rs. 1700874553.